Showing 227 results

Filters Content type: News, Editors' picks, About HIV Topic: Injectable & long-acting PrEP

The antiretroviral drug cabotegavir, administered every eight weeks as an injection, has been shown to be safe and effective in preventing HIV infection in men who have sex with men. Studies in women are ongoing and scientists are also working on a long-acting PrEP implant.

HIV Preventive Treatment Could Be Sold for One Thousandth of Current List Price

Editor's pick
Infectious Disease Society of America
21 October 2025

Can health systems keep pace with HIV prevention’s breakthrough?

Editor's pick
Devex (requires free registration)
15 September 2025